Esthesioneuroblastoma CT: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Esthesioneuroblastoma}}
{{Esthesioneuroblastoma}}
{{CMG}}{{AE}}{{Simrat}}
==Overview==


Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==CT==
CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3.
These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed


==References==
==References==

Revision as of 15:49, 13 January 2016

Esthesioneuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esthesioneuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esthesioneuroblastoma CT On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esthesioneuroblastoma CT

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esthesioneuroblastoma CT

CDC on Esthesioneuroblastoma CT

Esthesioneuroblastoma CT in the news

Blogs on Esthesioneuroblastoma CT

Directions to Hospitals Treating Esthesioneuroblastoma

Risk calculators and risk factors for Esthesioneuroblastoma CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

CT

CT is particularly useful in assessing bony destruction, although it cannot distinguish olfactory neuroblastomas from other tumors that arise in the same region. The mass is of soft tissue attenuation, with relatively homogeneous enhancement 3. Focal calcification are occasionally present 3. These tumors are relatively slow growing and thus, the bony margins are often remodeled and resorbed, rather than being aggressively destroyed

References

Template:Central nervous system tumors

Template:WH Template:WS